260 / 264
Selected Section Materials by Topic
I - 15
Schilling C, Stoeckli SJ, Haerle SK, et al. Sentinel European Node Trial (SENT): 3-year results of
sentinel node biopsy in oral cancer.
Eur J Cancer
. 2015; 51(18):2777-2784. EBM level 2
Quality of Life
Reeve BB, Cai J, Zhang H, et al. Factors that impact health-related quality of life over time for
individuals with head and neck cancer.
Laryngoscope
. 2016; 126(12):2718-2725. EBM level 4
Rettig EM, D'Souza G, Thompson CB, et al. Health-related quality of life before and after head and neck
squamous cell carcinoma: analysis of the Surveillance, Epidemiology, and End Results-Medicare Health
Outcomes Survey linkage.
Cancer
. 2016; 122(12):1861-1870. EBM level 4
Sethugavalar B, Teo MT, Buchan C, et al. Impact of prophylactic gastrostomy or reactive NG tube upon
patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma:
a matched pair analysis.
Oral Oncol
. 2016; 59:80-85. EBM level 3
Treatment Modalities Update: Robotic Surgery
Choby GW, Kim J, Ling DC, et al. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-
life outcomes.
JAMA Otolaryngol Head Neck Surg
. 2015; 141(6):499-504. EBM level 4
Kumar B, Cipolla MJ, Old MO, et al. Surgical management of oropharyngeal squamous cell carcinoma:
survival and functional outcomes.
Head Neck
. 2016; 38 Suppl 1:E1794-1802. EBM level 3
Treatment Modalities Update: Immunotherapy
Andtbacka RH, Agarwala SS, Ollila DW, et al. Cutaneous head and neck melanoma in OPTiM, a
randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating
factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
Head Neck
. 2016; 38(12):1752-
1758. EBM level 2
Yimaer W, Abudouyimu A, Tian Y, et al. Efficacy and safety of vascular endothelial growth factor
receptor tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of
randomized controlled trials.
Onco Targets Ther
. 2016; 9:1167-1173. EBM level 1
Inflammatory: GERD Role in Cancer Development and Prevention
Busch EL, Zevallos JP, Olshan AF. Gastroesophageal reflux disease and odds of head and neck
squamous cell carcinoma in North Carolina.
Laryngoscope
. 2016; 126(5):1091-1096. EBM level 3
Papagerakis S, Bellile E, Peterson LA, et al. Proton pump inhibitors and histamine 2 blockers are
associated with improved overall survival in patients with head and neck squamous carcinoma.
Cancer
Prev Res (Phila)
. 2014; 7(12):1258-1269. EBM level 3
Section 8: Otology and Neurotology
Migraine and Vertigo
Chang TP, Lin YW, Sung PY, et al. Benign paroxysmal positional vertigo after dental procedures: a
population-based case-control study.
PLOS One
. 2016; 11(4):e0153092. EBM level 3